AdaptHealth Corp. (AHCO) Cash Flow Statement

The gap between a large net loss and sizable positive operating cash flow suggests the losses are dominated by non-cash charges such as depreciation of the rental fleet and amortization, which the D&A line of $116.9M supports. The negative OCF/NI ratios across most quarters indicate that accrual-based earnings are a weak guide to cash generation here, so investors should monitor whether operating cash flow holds up once depreciation normalizes or fleet investment slows. The quality of this conversion remains uncertain without a full reconciliation of the non-cash add-backs.

The trajectory is volatile rather than trending, with FCF margins peaking at 19.6% in 2024Q2 and compressing sharply through 2025 and early 2026. This pattern suggests that capital intensity and working capital swings, rather than steady operating improvement, are driving the free cash flow outcome. Investors should treat the latest positive quarter cautiously given the prior negative readings.

The sustained CAPEX level relative to D&A of roughly $90M to $120M per quarter suggests the company is reinvesting at or above its depreciation rate, consistent with a rental-fleet model that must continually refresh devices. Because CapEx largely offsets operating cash generation, the reinvestment burden appears to limit free cash available for debt reduction. Whether this spending is maintenance or growth in character is not disclosed in the supplied data and warrants further investigation.

The absence of dividends and minimal repurchases indicates that retained cash is being directed toward reinvestment and deal activity rather than shareholder distributions. The acquisition spending in recent quarters is consistent with the roll-up strategy noted in prior analysis, yet with net losses persisting it is unclear whether these purchases are generating adequate returns. Investors should monitor whether acquired cash flows begin to offset the capital consumed by these transactions.